Stock screener

SRZN

Conviction 51HealthcareScan · Mon, Aug 10, 2026
SRZN$25.25-1.44%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 384.96K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Surrozen, Inc./DEBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.surrozen.com ↗
Price25.25
Change-1.44%
Gap+0.20%
Rel volume3.76×
Avg volume313.83K
Avg $ vol6.92M
SMA 2021.69
SMA 5022.93
SMA 20023.09
Price vs 50+10.12%
Price vs 200+9.35%
MA stackmixed
50/200 crossdeath · 2d
Supertrendup · 18.98
RSI (14)62
MACD hist0.61
MACD crossbull · 6d
Stoch %K / %D78 / 75
ADX (14)18
+DI / −DI28 / 13
RSI divergence—
MACD divergence—
ATR %+8.32%
ADR %9.00%
52w high34.13
52w low9.56
From 52w high-26.02%
Above 52w low+164.12%
New 52w highNo
SqueezeOff
Bollinger width29.54%
%B1.06
Donchian pos77.50%
Donchian high27.32
Donchian low18.12
AVWAP (52w high)23.74
vs AVWAP high+6.34%
AVWAP (52w low)22.72
vs AVWAP low+11.15%
OBV trendDown
Chaikin MF (20)-0.05
Today vs 20d3.76×
Avg vol (14d)384.96K
Avg vol (20d)313.83K
Avg $ vol (20d)6.92M
Market cap296.78M
RS 3m (vs SPY)-22.38%
RS 6m (vs SPY)+6.45%
RS line new highNo
Trend template5/8
Technical rank77.2
1 week+15.93%
1 month+8.88%
3 months-12.81%
6 months+10.75%
1 year+179.62%
YTD+17.17%
P/E-1.23
P/B-1.36
P/S85.35
P/FCF-9.77
EPS-32.37
Div yield—
ROE110.68%
ROA-209.35%
Debt/Eq—
Current12.14
EV/EBITDA-4.69
Gross margin—
Net margin—
Rev growth-67.37%
EPS growth-280.76%
Price target43.00
Target upside70.30%
Analyst ratingBuy
Institutional104.99%
Ent. value194.74M
Revenue5M
Net income50.18M
Gross profit—
Free cash flow-30.37M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out11.61M
Employees44
ListedThu, Aug 12, 2021
Free float4.11M
Float %47.9%
Short interest970.96K
Days to cover6.2d
Short volume65.2%
Squeeze score97 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.41 vs −$1.34
Last surprise+69.4% beat
Setup gradeC
Conviction51 / 100
Pattern quality—
Tech rank77.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance26.21
Support19.05
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SRZN

All disclosures →
No recent disclosed trades by Congress in SRZN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SRZN · 7 buys · 3 sells

InsiderSideShares
Kutzkey Tim
Director · Option (right to buy) · 2026-05-13
Grant5.55K
Haak-Frendscho Mary
Director · Director Stock Option (right to buy) · 2026-05-13
Grant5.55K
Rothenberg Mace
Director · Director Stock Option (right to buy) · 2026-05-13
Grant5.55K
Berkenblit Anna
Director · Director Stock Option (right to buy) · 2026-05-13
Grant5.55K
CHAI CHRISTOPHER Y
Director · Director Stock Option (right to buy) · 2026-05-13
Grant5.55K
WOODHOUSE DAVID J
Director · Director Stock Option (right to buy) · 2026-05-13
Grant5.55K
BJERKHOLT ERIC
Director · Director Stock Option (right to buy) · 2026-05-13
Grant5.55K
Williams Charles O
Chief Operating Officer · Common Stock · 2026-05-04
Sell2.04K
Parker Craig C
Chief Executive Officer · Common Stock · 2026-05-04
Sell4.52K
Li Yang
Exec. Vice President, Research · Common Stock · 2026-05-04
Sell1.58K

SEC filings

EDGAR filings in SRZN · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.